Twist Bioscience Corporation
TWST
$120.64
-$4.65-3.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 118.38M | 110.72M | 103.70M | 99.01M | 96.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 118.38M | 110.72M | 103.70M | 99.01M | 96.06M |
| Cost of Revenue | 55.92M | 53.59M | 49.73M | 48.17M | 44.76M |
| Gross Profit | 62.45M | 57.12M | 53.97M | 50.84M | 51.30M |
| SG&A Expenses | 80.71M | 76.09M | 69.74M | 63.76M | 63.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 154.66M | 149.37M | 136.60M | 128.94M | 126.18M |
| Operating Income | -36.28M | -38.66M | -32.90M | -29.93M | -30.12M |
| Income Before Tax | -34.74M | -43.98M | -30.25M | -26.88M | 20.58M |
| Income Tax Expenses | 311.00K | 43.00K | 253.00K | 257.00K | 191.00K |
| Earnings from Continuing Operations | -35.05M | -44.02M | -30.51M | -27.14M | 20.39M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.05M | -44.02M | -30.51M | -27.14M | 20.39M |
| EBIT | -36.28M | -38.66M | -32.90M | -29.93M | -30.12M |
| EBITDA | -29.80M | -32.44M | -27.01M | -26.03M | -24.36M |
| EPS Basic | -0.56 | -0.71 | -0.50 | -0.45 | 0.34 |
| Normalized Basic EPS | -0.35 | -0.37 | -0.31 | -0.28 | -0.29 |
| EPS Diluted | -0.56 | -0.71 | -0.50 | -0.45 | 0.33 |
| Normalized Diluted EPS | -0.35 | -0.37 | -0.31 | -0.28 | -0.29 |
| Average Basic Shares Outstanding | 62.40M | 61.70M | 61.08M | 60.42M | 60.00M |
| Average Diluted Shares Outstanding | 62.40M | 61.70M | 61.08M | 60.42M | 61.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |